Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 12 studies | 29% ± 14% | |
peripheral blood | 9 studies | 21% ± 5% | |
kidney | 8 studies | 25% ± 5% | |
brain | 7 studies | 32% ± 15% | |
intestine | 6 studies | 24% ± 10% | |
eye | 6 studies | 23% ± 9% | |
lymph node | 4 studies | 26% ± 12% | |
breast | 4 studies | 20% ± 4% | |
pancreas | 3 studies | 41% ± 5% | |
placenta | 3 studies | 68% ± 12% | |
adrenal gland | 3 studies | 25% ± 10% | |
prostate | 3 studies | 26% ± 7% | |
liver | 3 studies | 35% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 3470.97 | 966 / 966 | 100% | 166.84 | 527 / 527 |
prostate | 100% | 5541.20 | 245 / 245 | 100% | 811.42 | 502 / 502 |
breast | 100% | 2640.32 | 459 / 459 | 100% | 220.96 | 1116 / 1118 |
uterus | 100% | 3124.59 | 170 / 170 | 100% | 211.91 | 458 / 459 |
ovary | 100% | 5886.56 | 180 / 180 | 100% | 142.94 | 429 / 430 |
kidney | 100% | 5287.19 | 89 / 89 | 100% | 152.54 | 897 / 901 |
lung | 100% | 2982.20 | 576 / 578 | 100% | 172.26 | 1153 / 1155 |
stomach | 100% | 2436.29 | 359 / 359 | 99% | 156.64 | 284 / 286 |
adrenal gland | 100% | 7341.31 | 258 / 258 | 99% | 205.44 | 228 / 230 |
thymus | 100% | 4246.47 | 653 / 653 | 99% | 117.14 | 599 / 605 |
esophagus | 100% | 2730.63 | 1445 / 1445 | 99% | 138.62 | 181 / 183 |
bladder | 100% | 3401.10 | 21 / 21 | 99% | 174.22 | 498 / 504 |
skin | 99% | 3632.98 | 1799 / 1809 | 99% | 202.90 | 467 / 472 |
brain | 99% | 3480.31 | 2627 / 2642 | 97% | 111.17 | 683 / 705 |
pancreas | 94% | 1074.46 | 309 / 328 | 99% | 136.15 | 176 / 178 |
liver | 97% | 1171.54 | 220 / 226 | 83% | 61.61 | 338 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 172.37 | 29 / 29 |
spleen | 100% | 2258.75 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 147.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 50.96 | 1 / 1 |
blood vessel | 100% | 3297.16 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2276.32 | 1203 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 154.68 | 79 / 80 |
muscle | 98% | 1515.57 | 786 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 2414.04 | 816 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 2416.06 | 749 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006597 | Biological process | spermine biosynthetic process |
GO_0006555 | Biological process | methionine metabolic process |
GO_0006595 | Biological process | polyamine metabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0016768 | Molecular function | spermine synthase activity |
Gene name | SMS |
Protein name | Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase) Spermine synthase |
Synonyms | |
Description | FUNCTION: Catalyzes the production of spermine from spermidine and decarboxylated S-adenosylmethionine (dcSAM). . |
Accessions | ENST00000404933.7 [P52788-1] H7C2R7 ENST00000379404.5 [P52788-2] ENST00000457085.2 P52788 |